05-6890. National Institute on Drug Abuse; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Medical Writing, Report Preparation, and Project Management.

    Date: May 24, 2005.

    Time: 9 a.m. to 5 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.

    Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1439, If33c.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Regulatory Affairs Support.

    Date: June 7, 2005.

    Time: 9 a.m. to 5 p.m.Start Printed Page 17710

    Agenda: To review and evaluate contract proposals.

    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.

    Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1439, If33c.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS)

    Start Signature

    Dated: March 30, 2005.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 05-6890 Filed 4-6-05; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
5/24/2005
Published:
04/07/2005
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
05-6890
Dates:
May 24, 2005.
Pages:
17709-17710 (2 pages)
PDF File:
05-6890.pdf